Variations in Training of Surgical Oncologists: Proposal for a Global Curriculum C. AreA. CanigliaL. Wyld Healthcare Policy and Outcomes 27 April 2016 Pages: 1769 - 1781
Global Curriculum in Surgical Oncology Chandrakanth AreR. S. BermanR. A. Audisio Healthcare Policy and Outcomes 27 April 2016 Pages: 1782 - 1795
Intraoperative Radiation Therapy in Breast Cancer: Still Not Ready for Prime Time Chirag ShahJessica WobbAtif Khan Breast Oncology 22 February 2016 Pages: 1796 - 1798
The Search Continues for the Ideal Method to Localize Nonpalpable Breast Lesions James W. Jakub Breast Oncology 23 February 2016 Pages: 1799 - 1800
What are We Going to Do with Complete Responses After Chemoradiation of Rectal Cancer? Geerard L. Beets Colorectal Cancer 08 March 2016 Pages: 1801 - 1802
Factors Associated with Short-Term Mortality After Surgical Oncologic Emergencies Marianne R. F. BosscherEsther BastiaannetHarald J. Hoekstra Healthcare Policy and Outcomes Open access 09 November 2015 Pages: 1803 - 1814
Primary Tumor Resection and Multimodality Treatment for Patients with Metastatic Colon Cancer Nader N. MassarwehLinda T. LiDaniel A. Anaya Healthcare Policy and Outcomes 19 January 2016 Pages: 1815 - 1823
Pilot Study of a New Nonradioactive Surgical Guidance Technology for Locating Nonpalpable Breast Lesions Charles E. CoxNorbert Garcia-HenriquezSteven C. Shivers Breast Oncology 03 February 2016 Pages: 1824 - 1830
Do Patients After Reexcision Due to Involved or Close Margins Have the Same Risk of Local Recurrence as Those After One-Step Breast-Conserving Surgery? André HennigsValerie FuchsJoerg Heil Gynecologic Oncology 05 January 2016 Pages: 1831 - 1837
Optimal Surgical Management for Occult Breast Carcinoma: A Meta-analysis Francisco Igor B. MacedoJoseph J. EidVijay K. Mittal Breast Oncology 01 February 2016 Pages: 1838 - 1844
Using Multilevel Models to Explain Variation in Clinical Practice: Surgeon Volume and the Surgical Treatment of Breast Cancer Stacey FisherYutaka YasuiMarcy Winget Breast Oncology 02 February 2016 Pages: 1845 - 1851
Oncoplastic Breast-Conserving Surgery for Tumors Larger than 2 Centimeters: Is it Oncologically Safe? A Matched-Cohort Analysis Francesca De LorenziPietro LoschiRietjens Mario Breast Oncology 02 February 2016 Pages: 1852 - 1859
Asymptomatic Benign Papilloma Without Atypia Diagnosed at Ultrasonography-Guided 14-Gauge Core Needle Biopsy: Which Subgroup can be Managed by Observation? Soo-Yeon KimEun-Kyung KimHee Jung Moon Breast Oncology 26 February 2016 Pages: 1860 - 1866
Comparison of Long-Term Outcomes Between Emergency Surgery and Bridge to Surgery for Malignant Obstruction in Right-Sided Colon Cancer: A Multicenter Retrospective Study Bong-Hyeon KyeYoon Suk LeeHyung-Jin Kim Colorectal Cancer 26 January 2016 Pages: 1867 - 1874
Colorectal Cancer Resections in the Oldest Old Between 2011 and 2012 in The Netherlands N. M. VerweijA. H. W. SchiphorstM. E. Hamaker Colorectal Cancer 19 January 2016 Pages: 1875 - 1882
Local Recurrence in the Lateral Lymph Node Compartment: Improved Outcomes with Induction Chemotherapy Combined with Multimodality Treatment Miranda KustersSietske J. BosmanHarm J. T. Rutten Colorectal Cancer 02 February 2016 Pages: 1883 - 1889
KRAS Mutation Status Predicts Site-Specific Recurrence and Survival After Resection of Colorectal Liver Metastases Irrespective of Location of the Primary Lesion Junichi ShindohYujiro NishiokaNorihiro Kokudo Colorectal Cancer 19 January 2016 Pages: 1890 - 1896
Long-Term Survival Benefit and Potential for Cure after R1 Resection for Colorectal Liver Metastases Isamu HosokawaMarc-Antoine AllardRené Adam Hepatobiliary Tumors 28 January 2016 Pages: 1897 - 1905
Percutaneous Treatment of Localized Infiltrative Hepatocellular Carcinoma Developing on Cirrhosis Jean-Charles NaultGisèle NkontchouOlivier Seror Hepatobiliary Tumors 05 January 2016 Pages: 1906 - 1915
CD133 Expression at the Metastatic Site Predicts Patients’ Outcome in Colorectal Cancer with Synchronous Liver Metastasis Junko KishikawaShinsuke KazamaToshiaki Watanabe Hepatobiliary Tumors 29 January 2016 Pages: 1916 - 1923
Correlation of CTNNB1 Mutation Status with Progression Arrest Rate in RECIST Progressive Desmoid-Type Fibromatosis Treated with Imatinib: Translational Research Results from a Phase 2 Study of the German Interdisciplinary Sarcoma Group (GISG-01) Bernd KasperViktor GruenwaldFlorian Haller Bone and Soft Tissue Sarcomas 09 February 2016 Pages: 1924 - 1927
The 7th Edition of the AJCC Staging Classification Correlates with Biologic Behavior of Mucinous Appendiceal Tumor with Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) Vladimir MilovanovArmando SardiVadim Gushchin Gastrointestinal Oncology 29 December 2015 Pages: 1928 - 1933
Tumor Infiltrative Pattern Predicts Sites of Recurrence After Curative Gastrectomy for Stages 2 and 3 Gastric Cancer Mitsuro KandaAkira MizunoYasuhiro Kodera Gastrointestinal Oncology 03 February 2016 Pages: 1934 - 1940
Factors Associated with Readmission After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis Alexander S. MartinDaniel E. AbbottSyed A. Ahmad Gastrointestinal Oncology 02 February 2016 Pages: 1941 - 1947
Frequency of Resection After Preoperative Chemotherapy or Chemoradiotherapy for Gastric Adenocarcinoma Brian BadgwellMariela BlumJaffer Ajani Gastrointestinal Oncology 11 February 2016 Pages: 1948 - 1955
Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy Haejin InOlga KantorMitchell C. Posner Gastrointestinal Oncology 11 January 2016 Pages: 1956 - 1962
Risk Factors for the Loss of Lean Body Mass After Gastrectomy for Gastric Cancer Toru AoyamaTsutomu SatoTakaki Yoshikawa Gastrointestinal Oncology 13 January 2016 Pages: 1963 - 1970
Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility? C. S. ChiaB. Youthe BIG RENAPE Group Gastrointestinal Oncology 11 January 2016 Pages: 1971 - 1979
Splenectomy Increases Postoperative Complications Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Francois DagbertRemy ThievenazOlivier Glehen Gastrointestinal Oncology 25 February 2016 Pages: 1980 - 1985
Effect of EGFR and p-AKT Overexpression on Chromosomal Instability in Gastric Cancer Yuichi HisamatsuEiji OkiYoshihiko Maehara Gastrointestinal Oncology 04 February 2016 Pages: 1986 - 1992
Adjuvant Trametinib Delays the Outgrowth of Occult Pancreatic Cancer in a Mouse Model of Patient-Derived Liver Metastasis Timothy E. NewhookJames M. LindbergTodd W. Bauer Pancreatic Tumors 04 February 2016 Pages: 1993 - 2000
Laparoscopic Insulinoma Enucleation from the Retro-Pancreatic Neck: A Stepwise Approach Claudius ConradGuillaume PassotJeffrey E. Lee Original Article – Pancreatic Tumors 09 March 2016 Pages: 2001 - 2001
Elderly Patients Strongly Benefit from Centralization of Pancreatic Cancer Surgery: A Population-Based Study Lydia G. M. van der GeestMarc G. H. BesselinkValery E. P. P. Lemmens Pancreatic Tumors 21 January 2016 Pages: 2002 - 2009
Pancreatic Ductal Adenocarcinoma is Spread to the Peripancreatic Soft Tissue in the Majority of Resected Cases, Rendering the AJCC T-Stage Protocol (7th Edition) Inapplicable and Insignificant: A Size-Based Staging System (pT1: ≤2, pT2: >2–≤4, pT3: >4 cm) is More Valid and Clinically Relevant Burcu SakaSerdar BalciVolkan Adsay Pancreatic Tumors 29 January 2016 Pages: 2010 - 2018
Prognostic Impact of Para-Aortic Lymph Node Micrometastasis in Pancreatic Ductal Adenocarcinoma Toshiaki KomoYoshiaki MurakamiTaijiro Sueda Pancreatic Tumors 08 February 2016 Pages: 2019 - 2027
Pancreatectomy with Mesenteric and Portal Vein Resection for Borderline Resectable Pancreatic Cancer: Multicenter Study of 406 Patients Giovanni RamacciatoGiuseppe NigriUgo Boggi Pancreatic Tumors 18 February 2016 Pages: 2028 - 2037
Clinical Outcomes and Prognostic Factors for Salivary Duct Carcinoma: A Multi-Institutional Analysis of 141 Patients Kuninori OtsukaYorihisa ImanishiToshitaka Nagao Head and Neck Oncology Open access 20 January 2016 Pages: 2038 - 2045
The Dual Inhibition of Met and EGFR by ME22S, a Novel Met/EGFR Bispecific Monoclonal Antibody, Suppresses the Proliferation and Invasion of Laryngeal Cancer Bok-Soon LeeHaeng-Jun KimChul-Ho Kim Head and Neck Oncology 26 January 2016 Pages: 2046 - 2053
Comparison of Oncological and Functional Outcomes between Initial Surgical versus Non-Surgical Treatments for Hypopharyngeal Cancer Jeon Yeob JangEun-Hye KimHan-Sin Jeong Head and Neck Oncology 19 January 2016 Pages: 2054 - 2061
Health-Related Quality of Life for Patients Who have In-Transit Melanoma Metastases Treated with Isolated Limb Perfusion Ann-Sophie Lindqvist BaggeIlan Ben-ShabatRoger Olofsson Bagge Melanomas 11 February 2016 Pages: 2062 - 2069
Magnetic Technique for Sentinel Lymph Node Biopsy in Melanoma: The MELAMAG Trial Bauke AnningaSamantha H. WhiteMELAMAG Multicentre Trialists Group Melanomas 19 February 2016 Pages: 2070 - 2078
Blood Loss and Transfusion Requirements in Metastatic Spinal Tumor Surgery: Evaluation of Influencing Factors Naresh KumarAye Sandar ZawRaymond Goy Neuro-Oncology 27 January 2016 Pages: 2079 - 2086
Solitary Lymph Node Recurrence of Esophageal Squamous Cell Carcinoma: Surgical Failure or Systemic Disease? Tomoki MakinoMakoto YamasakiYuichiro Doki Thoracic Oncology 13 January 2016 Pages: 2087 - 2093
A Population-Based Cost Analysis of Thoracoscopic Versus Open Lobectomy in Primary Lung Cancer Bing-Yen WangJing-Yang HuangYung-Po Liaw Thoracic Oncology Open access 04 February 2016 Pages: 2094 - 2098
Minor Components of Micropapillary and Solid Subtypes in Lung Adenocarcinoma are Predictors of Lymph Node Metastasis and Poor Prognosis Yue ZhaoRui WangHaiquan Chen Thoracic Oncology Open access 02 February 2016 Pages: 2099 - 2105
Postoperative Infectious Complications are Associated with Adverse Oncologic Outcomes in Esophageal Cancer Patients Undergoing Preoperative Chemotherapy Kotaro YamashitaTomoki MakinoYuichiro Doki Thoracic Oncology 11 January 2016 Pages: 2106 - 2114
Epidermal Growth Factor Receptor Mutation Status and Treatment Outcome for R0-Resected Patients with Stage 3 Non-small Cell Lung Cancer Song Ran LiuBo QiuHui Liu Thoracic Oncology 17 February 2016 Pages: 2115 - 2122